Verastem reported $12.45M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 400K 213K Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Curis USD 5.61M 1.52M Dec/2025
Cytokinetics USD 24.71M 80.91M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Laboratory Of America USD 695.7M 145.1M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 148.84M 41.34M Mar/2026
Verastem USD 12.45M 2.56M Dec/2025